417 related articles for article (PubMed ID: 31919794)
1. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
[TBL] [Abstract][Full Text] [Related]
2. Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania.
Barry A; Olsson S; Khaemba C; Kabatende J; Dires T; Fimbo A; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; van Puijenbroek E; Bergman U; Nkayamba A; Mugisha M; Gurumurthy P; Aklillu E
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671293
[TBL] [Abstract][Full Text] [Related]
3. National medicines regulatory authorities financial sustainability in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance activities in ASEAN countries.
Suwankesawong W; Dhippayom T; Tan-Koi WC; Kongkaew C
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1061-9. PubMed ID: 27174034
[TBL] [Abstract][Full Text] [Related]
5. Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal.
Samukange WT; Kluempers V; Porwal M; Mudyiwenyama L; Mutoti K; Aineplan N; Gardarsdottir H; Mantel-Teeuwisse AK; Nuebling CM
BMC Health Serv Res; 2021 Nov; 21(1):1258. PubMed ID: 34801022
[TBL] [Abstract][Full Text] [Related]
6. Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis.
Tiemersma EW; Ali I; Alemu A; Avong YK; Duga A; Elagbaje C; Isah A; Kay A; Mmbaga BT; Mmari E; Mwamwitwa K; Nhlabatsi S; Sintayehu K; Arefayne A; Teferi M; Cobelens F; Härmark L
BMC Health Serv Res; 2021 Oct; 21(1):1062. PubMed ID: 34625085
[TBL] [Abstract][Full Text] [Related]
7. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
[TBL] [Abstract][Full Text] [Related]
9. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale.
Rachlis B; Karwa R; Chema C; Pastakia S; Olsson S; Wools-Kaloustian K; Jakait B; Maina M; Yotebieng M; Kumarasamy N; Freeman A; de Rekeneire N; Duda SN; Davies MA; Braitstein P
Drug Saf; 2016 Oct; 39(10):959-76. PubMed ID: 27282427
[TBL] [Abstract][Full Text] [Related]
10. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
11. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
12. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Masuka JT; Khoza S
Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance in the Middle East: a survey of 13 arabic-speaking countries.
Wilbur K
Drug Saf; 2013 Jan; 36(1):25-30. PubMed ID: 23315293
[TBL] [Abstract][Full Text] [Related]
15. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
[TBL] [Abstract][Full Text] [Related]
16. Pharmacovigilance in China: development and challenges.
Zhao Y; Wang T; Li G; Sun S
Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
[TBL] [Abstract][Full Text] [Related]
17. Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.
Muñoz MA; Dal Pan GJ; Wei YJ; Delcher C; Xiao H; Kortepeter CM; Winterstein AG
Drug Saf; 2020 Apr; 43(4):329-338. PubMed ID: 31912439
[TBL] [Abstract][Full Text] [Related]
18. Progress towards the 2020 fast track HIV/AIDS reduction targets across ages in Ethiopia as compared to neighboring countries using global burden of diseases 2017 data.
Mirkuzie AH; Ali S; Abate E; Worku A; Misganaw A
BMC Public Health; 2021 Feb; 21(1):285. PubMed ID: 33541303
[TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
[TBL] [Abstract][Full Text] [Related]
20. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
